Genetic variation in neuropeptide Y interacts with childhood trauma to influence anxiety sensitivity

Anxiety Stress Coping. 2021 Jul;34(4):450-464. doi: 10.1080/10615806.2021.1876225. Epub 2021 Jan 24.

Abstract

Background and objectives: Anxiety sensitivity (AS) refers to a fear of the negative implications of anxiety, and arises due to gene-environment interactions. We investigated whether genetic variation in two neuropeptides implicated in the stress response, neuropeptide Y (NPY) and pituitary adenylate cyclase-activating polypeptide receptor 1, interacted with childhood trauma (CT) to influence AS.

Design and methods: This cross-sectional study examined the CT x genetic variant effects on AS in 951 adolescents who self-identified as Xhosa or South African Colored (SAC) ethnicity.

Results: In Xhosa females, the NPY rs5573 A allele and rs3037354 deletion variant were associated with increased (p = 0.035) and decreased (p = 0.034) AS, respectively. The interaction of CT and the NPY rs5574 A allele increased AS in SAC female participants (p = 0.043). The rs3037354 deletion variant protected against AS with increased CT in SAC male participants (p = 0.011).

Conclusions: The NPY rs5574 A allele and rs3037354 deletion variant interact with CT to act as risk and protective factors, respectively, for AS in an ethnicity- and sex- differentiated manner. Our results reaffirm the role of NPY and gene-environment interactions in anxiety-related behaviors and reinforce the need for psychiatric genetics studies in diverse populations.

Keywords: Anxiety; childhood trauma; gene-environment; genetics; neuropeptide Y; pituitary adenylate cyclase-activating polypeptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adverse Childhood Experiences* / ethnology
  • Anxiety* / ethnology
  • Anxiety* / genetics
  • Cross-Sectional Studies
  • Female
  • Genetic Variation
  • Humans
  • Male
  • Neuropeptide Y* / genetics
  • South Africa

Substances

  • Neuropeptide Y